文献速递乳房整形与再造美容整形

跨性别女性乳房增大:前瞻性对比研究

Breast Augmentation in Transgender Women: A Prospective Comparative Study.
PubMed 文献 · Plast Reconstr Surg · 2026-08-07

总体并发症率为3.7%,两组无显著差异;乳房下皱襞组二次美学修整更常见(28.6% vs. 7.5%;p=0.026)。两组BREAST-Q各领域评分均高且无显著差异。

要点

  • 乳晕周围与乳房下皱襞入路并发症率相似(总体3.7%)
  • 乳房下皱襞组二次美学修整更频繁(28.6% vs. 7.5%;p=0.026)
  • 两组BREAST-Q满意度评分均高且无显著差异

核心结论

  • 乳晕周围与乳房下皱襞入路乳房增大的并发症率和BREAST-Q结局相似。
  • 在患者自主选择设置下,两种入路均与高水平的患者报告满意度相关。

研究设计与样本

  • 纳入标准:年龄18岁或以上、体重指数低于30、至少12个月激素治疗。
  • 排除标准:既往乳房手术或填充剂注射。
  • 入路类型由每位患者在术前咨询后选择。

主要发现

  • 两组除假体腔隙位置外具有可比性。
  • 总体并发症率为3.7%,组间无显著差异。
  • 二次美学修整在乳房下皱襞组更常见(28.6% vs. 7.5%;p=0.026)。
  • BREAST-Q各领域评分均高,组间无显著差异。

关键数值与推荐

  • 总体并发症率为3.7%。
  • 二次美学修整率:乳房下皱襞组28.6%,乳晕周围组7.5%(p=0.026)。

临床怎么用

  • 对于符合条件的AMABp,乳晕周围与乳房下皱襞入路均可考虑,并发症率和满意度相似。
  • 需告知患者乳房下皱襞入路二次美学修整风险可能更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Breast augmentation is a key component of chest feminization in assigned male at birth patients (AMABp). Although both the inframammary and periareolar approaches are used, few studies have compared their outcomes in transgender women. This study aimed to evaluate both techniques regarding surgical outcomes, complications, and patient-reported satisfaction using the BREAST-Q questionnaire. MATERIAL AND METHODS: A prospective study was conducted on AMABp undergoing primary breast augmentation performed by two senior surgeons between November 2016 and December 2024. Inclusion criteria included age 18 years or older, body mass index below 30, and at least 12 months of hormone therapy. Patients with previous breast surgery or filler injections were excluded. The type of incision (periareolar or inframammary) was chosen by each patient after preoperative counseling. Postoperative outcomes and satisfaction were recorded. The BREAST-Q Version 2 Augmentation Module was administered online at least 12 months postoperatively. Data were analysed using Mann-Whitney U and Fisher's exact tests (p < 0.05). RESULTS: Ninety-five AMABp were included (55 periareolar, 40 inframammary). Groups were comparable except for implant pocket location. The overall complication rate was 3.7%, with no significant intergroup differences. Secondary aesthetic revisions were more frequent in the inframammary group (28.6% vs. 7.5%; p= 0.026). BREAST-Q scores were high across all domains, without significant differences between groups. CONCLUSION: Periareolar and inframammary breast augmentation resulted in similar complication rates and BREAST-Q outcomes. In a patient-selected setting, both approaches were associated with high levels of patient-reported satisfaction.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Grimaud M, La Padula S, Aidan B, et al. Breast Augmentation in Transgender Women: A Prospective Comparative Study. Plast Reconstr Surg. 2026. PMID: 42566669. doi:10.1097/PRS.0000000000013374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。